Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.1 USD | -2.94% | +2.20% | -10.84% |
Sales 2024 * | 2.8B 3.04B | Sales 2025 * | 2.77B 3B | Capitalization | 20.88B 22.65B |
---|---|---|---|---|---|
Net income 2024 * | -435M -472M | Net income 2025 * | -508M -551M | EV / Sales 2024 * | 2.18 x |
Net cash position 2024 * | 14.78B 16.03B | Net cash position 2025 * | 13.76B 14.93B | EV / Sales 2025 * | 2.57 x |
P/E ratio 2024 * |
-48
x | P/E ratio 2025 * |
-42.9
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | -2.94% | ||
1 week | +2.20% | ||
Current month | +5.94% | ||
1 month | +7.90% | ||
3 months | +2.92% | ||
6 months | -4.27% | ||
Current year | -10.84% |
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 08-06-01 |
Özlem Türeci
FOU | Founder | 57 | 08-06-01 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 21-12-31 |
Director/Board Member | 67 | 08-06-01 | |
Helmut Jeggle
CHM | Chairman | 53 | 08-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.92% | 1 M€ | -0.95% | - | |
2.63% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 94.1 | -2.94% | 897,787 |
24-05-24 | 96.95 | -2.07% | 1,245,252 |
24-05-23 | 99 | -3.23% | 1,553,710 |
24-05-22 | 102.3 | +11.11% | 3,753,038 |
24-05-21 | 92.07 | -0.43% | 609,315 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.84% | 22.71B | |
+9.83% | 115B | |
+10.80% | 105B | |
-1.69% | 21.83B | |
-10.23% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B | |
-30.73% | 7.6B |
- Stock Market
- Equities
- BNTX Stock